UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 23, 2020

PFIZER INC.

(Exact name of registrant as specified in its charter)

Delaware

1-3619

13-5315170

(State or other

(Commission File

(I.R.S. Employer

jurisdiction of

Number)

Identification No.)

incorporation)

235 East 42nd Street

10017

New York,

New York

(Zip Code)

(Address of principal executive offices)

Registrant s telephone number, including area code:

(212) 733-2323

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.05 par value

PFE

New York Stock Exchange

0.250% Notes due 2022

PFE22

New York Stock Exchange

1.000% Notes due 2027

PFE27

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.07 Submission of Matters to a Vote of Security Holders

(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 23, 2020.

(b) Shareholders voted on the matters set forth below.

1. The nominees for election to the Company s Board of Directors set forth in Item 1 to the Company s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 13, 2020 were elected to hold office until the Company s next Annual Meeting of Shareholders, based upon the following votes:

Nominee

Votes For

Votes Against

Abstentions

Broker non-vote

Ronald E. Blaylock

3,838,566,625

56,381,770

13,596,621

812,957,533

Albert Bourla

3,694,789,467

186,110,953

27,646,791

812,957,533

W. Don Cornwell

3,804,895,768

90,180,287

13,471,156

812,957,533

Joseph J. Echevarria

3,598,011,274

298,143,259

12,392,678

812,957,533

Scott Gottlieb

3,875,072,029

20,928,717

12,546,465

812,957,533

Helen H. Hobbs

3,874,592,839

22,787,784

11,166,587

812,957,533

Susan Hockfield

3,879,605,512

18,539,362

10,402,337

812,957,533

James M. Kilts

3,257,924,746

638,358,601

12,263,863

812,957,533

Dan R. Littman

3,870,004,992

26,060,961

12,481,257

812,957,533

Shantanu Narayen

3,865,221,904

30,969,956

12,355,350

812,957,533

Suzanne Nora Johnson

3,733,297,401

164,478,705

10,771,104

812,957,533

James Quincey

3,871,405,786

25,379,651

11,761,773

812,957,533

James C. Smith

3,852,504,316

43,772,088

12,270,806

812,957,533

2. The proposal to ratify the selection of KPMG LLP as the Company s independent registered public accounting firm for the 2020 fiscal year was approved based upon the following votes:

Votes for approval

4,517,781,714

Votes against

189,300,865

Abstentions

14,422,165

Broker non-votes

n/a

3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:

Votes for approval

3,687,626,065

Votes against

193,562,262

Abstentions

27,358,009

Broker non-votes

812,957,533

4. The shareholder proposal regarding right to act by written consent was not approved based upon the following votes:

Votes for approval

614,675,966

Votes against

3,262,924,232

Abstentions

30,946,935

Broker non-votes

812,957,533

5. The shareholder proposal regarding enhancing proxy access was not approved based upon the following votes:

Votes for approval

1,172,526,227

Votes against

2,707,722,195

Abstentions

28,298,711

Broker non-votes

812,957,533

6. The shareholder proposal regarding report on lobbying activities was not approved based upon the following votes:

Votes for approval

795,529,692

Votes against

3,070,923,866

Abstentions

42,093,653

Broker non-votes

812,957,533

7. The shareholder proposal regarding independent chair policy was not approved based upon the following votes:

Votes for approval

1,320,327,998

Votes against

2,562,531,292

Abstentions

25,687,720

Broker non-votes

812,957,533

8. The shareholder proposal regarding gender pay gap was not approved based upon the following votes:

Votes for approval

1,416,237,122

Votes against

2,296,745,539

Abstentions

195,562,451

Broker non-votes

812,957,533

9. Susan Desmond-Hellmann was elected to the Company s Board of Directors to hold office until the Company s next Annual Meeting of Shareholders, based upon the following votes:

Nominee

Votes For

Votes Against

Abstentions

Broker non-vote

Susan Desmond-Hellmann

3,585,622,194

23,967,398

36,831,173

1,050,149,944

(c) Not applicable

(d) Not applicable

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PFIZER INC.

Dated: April 24, 2020

By:

/s/ Margaret M. Madden

Margaret M. Madden

Senior Vice President and Corporate Secretary

Chief Governance Counsel